Press Releases

Media Inquiries - media@caredxinc.com

 
Press Releases
Date Title and Summary View
Mar 24, 2014
Mar 28, 2014
Apr 25, 2014
Jun 3, 2014
Jun 11, 2014
Jun 16, 2014
Jul 17, 2014 Brisbane, CA July 17, 2014 CareDx, Inc. (NASDAQ: CDNA) announced the pricing of its initial public offering of 4,000,000 shares of its common stock at a price to the public of $10 per share, before underwriter discounts. In addition, CareDx has granted the underwriters a 30-day option to purchase up to 600,000 additional shares of common stock...
Jul 28, 2014 BRISBANE, Calif., July 28, 2014 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value, non-invasive surveillance solutions for transplant recipients today announced the results of its cohort studies of blood samples from the multicent...
Jul 31, 2014 BRISBANE, Calif. and PITTSBURGH, July 31, 2014 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA) a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value, non-invasive surveillance solutions for transplant recipients and Allegheny General Hospital (AGH), a leading transplant center locat...
Aug 14, 2014 BRISBANE, Calif., Aug. 14, 2014 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value, non-invasive surveillance solutions for transplant recipients, today announced that it will release its financial results for the second quarter of...
Page:
1
... NextLast
= add release to Briefcase